Homology Medicines Inc. (FIXX)
NASDAQ: FIXX
· Real-Time Price · USD
0.93
0.00 (0.26%)
At close: Mar 25, 2024, 9:00 PM
Homology Medicines Revenue
Homology Medicines reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending March 31, 2025, Homology Medicines generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
0
Employees
7
Market Cap
3.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | -100.00% |
| Dec 31, 2023 | 1.16M | -63.97% |
| Dec 31, 2022 | 3.21M | -90.56% |
| Dec 31, 2021 | 33.97M | +1157.25% |
| Dec 31, 2020 | 2.7M | +62.18% |
| Dec 31, 2019 | 1.67M | -54.78% |
| Dec 31, 2018 | 3.68M | +Infinity% |
| Dec 31, 2017 | 0 | n/a |
| Dec 31, 2016 | 0 | n/a |